Document is current

Article History

Received: 6 April 2022

Accepted: 24 November 2022

First Online: 2 January 2023

Declarations

:

: Ethics approval was obtained from the Health Research Ethics Board - Health Panel at the University of Alberta (Pro00085385) and all methods were performed in accordance with the relevant guidelines and regulations established by the committee. The need for written informed consent was waived by the Health Research Ethics Board - Health Panel ethics committee due to retrospective nature of the study. This research was conducted in accordance with the principles of the Declaration of Helsinki.

: Not applicable.

: Dr. Rukia Swaleh: Nothing to disclose.

: Taylor McGuckin: Nothing to disclose.

: Dr. Campbell-Scherer reports personal fees from Pfizer, grants from NOVAD (Univ. Hospital Foundation, Úlberta Gov. & Novo Nordisk), CIHR, Alberta Innovates - Health Solutions, Alberta Government (Physician Learning Program)Ð outside the submitted work .

: Brock Setchell: Nothing to disclose.

: Dr. Peter Senior: Dr. Senior reports payments for clinical services from the Alberta Academic Medicine and Health Services Plan. He was section chief for endocrinology in the Edmonton Zone and co-chair of the Edmonton Zone Diabetes Quality Council when the work was conducted.

: Dr. Roseanne O Yeung: Dr. Yeung reports personal fees from Merck, personal fees from Diabetes Canada, personal fees from Novo Nordisk, personal fees from Sanofi, grants from Astra Zeneca, grants from Allergen, outside the submitted work.